$SNTA MADRIGAL PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in MADRIGAL PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
MADRIGAL PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Bahcall Safi R | President and CEO | 2,053,135 | 0 | Nov 15 2013 | |||
| BAILEY MICHAEL P | Sr. VP, Chief Comm. Officer | 29,627 | 0 | Aug 06 2010 | |||
| Barsoum James G | Sr. VP, Research | 0 | 0 | Apr 14 2009 | |||
| BATE KENNETH | Director | 0 | 0 | Jun 18 2020 | |||
| BAY CITY CAPITAL FUND LLC | 10% Owner | 2,310,521 | 0 | Dec 01 2020 | |||
| Bernitz Steven B | SVP, Corporate Development | 25,000 | 0 | Dec 20 2013 | |||
| Chadwick Jeremy G | Sr. VP, Pgm Mgmt and Clin Ops | 23,761 | 0 | Mar 03 2010 | |||
| Chen Lan Bo | Director | 620,035 | 0 | Aug 07 2009 | |||
| Chen Lin Huey | 10% Owner | 620,035 | 0 | Aug 07 2009 | |||
| CRAVES FRED B | Director | 2,260,791 | 0 | Sep 04 2020 | |||
| CxSynta LLC | 10% Owner | 7,761,716 | 0 | Feb 13 2007 | |||
| Daly James M | Director | 0 | 0 | Jun 18 2020 | |||
| Ehrlich Keith S | VP, Fin. and Admin., CFO | 17,573 | 0 | Mar 05 2014 | |||
| Folkman Judah | Director | 7,676 | 0 | Jul 03 2007 | |||
| FRIEDMAN PAUL A | Chief Executive Officer | 161,128 | 0 | Feb 23 2021 | |||
| FRIEDMAN PAUL A | Director | 0 | 0 | Jul 03 2014 | |||
| Gollust Keith R | Director | 1,539,169 | 0 | Jun 18 2020 | |||
| Jacobson Eric W | Sr. VP, Research and CMO | 25,300 | 0 | Apr 14 2009 | |||
| Kovner Bruce | Director | 340,970 | 0 | Dec 08 2015 | |||
| Kovner Bruce | Director | 5,269,685 | 0 | Dec 09 2011 | |||
| Kovner Bruce | Director | 8,421,467 | 0 | Oct 01 2014 | |||
| Koya Keizo | Sr. VP, Drug Development | 12,999 | 0 | Mar 08 2012 | |||
| KUFE DONALD W | Director | 0 | 0 | Jul 06 2015 | |||
| KUFE DONALD W | Director | 25,748 | 0 | Jul 03 2014 | |||
| Levy Richard S | Director | 7,200 | 0 | Jun 18 2020 | |||
| Lynch Brian Joseph | SVP and General Councel | 0 | 0 | Feb 23 2021 | |||
| McMahon Arthur | SVP, Human Resources | 0 | 0 | Mar 04 2015 | |||
| MILLIGAN DAVID V | Director | 0 | 0 | Jun 18 2020 | |||
| Morenstein Scott D | Director | 17,857 | 0 | Jan 05 2016 | |||
| Ramachandra Sumant | President, R&D | 75,000 | 0 | Mar 13 2013 | |||
| REARDON WILLIAM S | Director | 49,392 | 0 | Jul 06 2015 | |||
| REARDON WILLIAM S | Director | 41,439 | 0 | Jul 03 2014 | |||
| Rieder Wendy E | Former SVP, Gen. Counsel | 26,280 | 0 | Jul 22 2016 | |||
| Schneebaum Marc R | Chief Financial Officer | 49,033 | 0 | Feb 23 2021 | |||
| Schneebaum Marc R | SVP and CFO | 75,000 | 0 | Dec 10 2014 | |||
| Schor Chen | Former President and CEO | 51,428 | 0 | Jul 22 2016 | |||
| Schor Chen | Executive VP and COO | 150,000 | 0 | Dec 10 2014 | |||
| Singh Amar | Sr. VP, Chief Business Officer | 21,031 | 0 | Mar 07 2013 | |||
| Sukhija Remy | Chief Commercial Officer | 0 | 0 | Feb 23 2021 | |||
| Taub Rebecca | See Remarks | 655,540 | 0 | Feb 23 2021 | |||
| Vukovic Vojo | SVP, Chief Medical Officer | 35,249 | 0 | Oct 06 2015 | |||
| Whitaker Anne Clem | President and CEO | 0 | 0 | Mar 04 2015 | |||
| Whitaker Anne Clem | President and CEO | 500,000 | 0 | Sep 04 2014 | |||
| Williams Martin D | Sr. VP, Business Dev., CBO | 200 | 0 | Feb 29 2008 | |||
| WILSON ROBERT N | Director | 760,936 | 0 | Jul 06 2015 | |||
| WILSON ROBERT N | Director | 704,118 | 0 | Jul 03 2014 |